← Browse by Condition

Medical Condition

hiv

Total Trials

32

Recruiting Now

32

Trial Phases

Phase 1, Phase 2, Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for hiv sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — hiv Clinical Trials

How many clinical trials are currently recruiting for hiv?

ClinicalMetric currently tracks 32 actively recruiting clinical trials for hiv, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 32. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for hiv?

hiv research spans Phase 1 (2 trials), Phase 2 (2 trials), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a hiv clinical trial?

Eligibility criteria for hiv trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

2

Phase 2

2

Phase 3

1

Phase 4

1

Top Sponsors

Johns Hopkins University 4 trials

National Institute of Allergy and Infectious Diseases (NIAID) 3 trials

Boston University 2 trials

University of Alabama at Birmingham 2 trials

University of California, Los Angeles 2 trials

Recruiting Clinical Trials

Skeletal Muscle Energetics and Fatiguability in Older Individuals

Johns Hopkins University

A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities

Tulane University

NCT07390955 Phase 1

A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1

United States, Peru,...

National Institute of Allergy ...

Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection

National Institute of Allergy ...

Gathering Records to Evaluate Antiretroviral Treatment-Malawi ( GREAT )

Boston University

Wellness Intervention for Smoking and HIV

University of Arizona

Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV

Medical College of Wisconsin

Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression Among Older Gay and Bisexual Men

Fenway Community Health

Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV

United States, Brazi...

University of Washington

NCT06880380 Phase 1

The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients

Institute of Hematology & Bloo...

Platelets Target the Circulating HIV Reservoir: Implications for Immunological Failure

Tourcoing Hospital

1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV

Johns Hopkins University

Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama

University of Alabama at Birmi...

NCT05413122 Phase 2, Phase 3

Evaluating Smoking Cessation Interventions for PWH in South Africa

Johns Hopkins University

Zn Supplementation in HIV Immunological Non Responders

Parc de Salut Mar

Gathering Online for Dialogue and Discussion to Enhance Social Support

RTI International

Ongoing Dynamic Choice to Address HIV Treatment Interruption in Malawi

University of California, Los ...

Viral Load in Blood and Lymph Tissues in People Living With HIV

National Institute of Allergy ...

New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease

Indiana University

We-INtervention Among Chinese HIV-serodiscordant Male Couples

City University of Hong Kong

HIV, Equity, and Addiction Training (HEAT) Program

University of Alabama at Birmi...

Streamlining Telehealth for Expanded PrEP Utilization Through Community Partnerships

University of Pennsylvania

NCT07040592 Phase 2

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide

Yale University

Change My Story Task Shifted Mental Health Intervention

Massachusetts General Hospital

Behavioral and Psychosocial Characteristics of Clients Accessing Services at IHRI

Institute of HIV Research and ...

PrEP Readiness Interventions for Sustained Motivation (PRISM)

Florida International Universi...

NCT06967753 Phase 4

Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH)

Mentor Moms+ Study

University of California, Los ...

A Study to Improve Skeletal Muscle in Veterans With HIV

VA Office of Research and Deve...

Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

Johns Hopkins University

Behavioral Risk Identification and Decision Guidance for HIV Engagement

Boston University

Cash Transfers to Pregnant Women With HIV

University of Pennsylvania

Related Conditions

smoking cessation (2) hiv infections (1) chlamydia (1) gonorrhea (1) syphilis (1) sleep (1) cardiovascular diseases (1) heart failure (1) hiv infected individuals (1) violence domestic (1) stigma social (1) engagement patient (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology